Aug. 5 at 7:07 PM
$RNXT quietly building momentum!
RenovoRx is reshaping chemo delivery with RenovoCath, a targeted device that minimizes side effects and enables faster, even same-day recovery. CEO Shaun Bagai calls it a new standard in localized cancer care.
Key Highlights:
✅ RenovoCath targets tumors directly, minimizing systemic side effects
✅ Patients report less fatigue, nausea, and immune suppression
✅ Faster outpatient recovery, some return to daily life same day
Sales team now engaging major cancer centers across the U.S.
Communicated Disclaimer -https://chartingdaily.com/RNXT-stock
$YMAB $STAA $STTK